美国 · 平台与数据 · Yahoo Finance

Pfizer (PFE) Signs New Drug Discovery Pact Focused On Sec61 Inhibitors

来源：Yahoo Finance · 美国 8 小时前

Pfizer (NYSE:PFE) signed a new research collaboration and license agreement with Enodia Therapeutics to develop Sec61 inhibitors. The arrangement centers on small-molecule Sec61…

在 Yahoo Finance 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)

Pfizer (PFE) Signs New Drug Discovery Pact Focused On Sec61 Inhibitors

推荐阅读

Financial Institutions (FISI) Set to Release Quarterly Earnings on Thursday

IBM expects 2026 revenue growth of 4% to 5% while raising free cash flow growth view to more than $1B

Is This Cryptocurrency a Potential Millionaire-Maker?

My father-in-law, 81, sold his $75,000 home and paid off his daughter’s $50,000 debt. What happens to him now?

Nokia reports 9% Q3 sales growth, raises restructuring costs

SPCX Stock Eyes Best Week In Nearly 3 Months — But Analyst Warns Investors May Have To ‘Wait Decades’ To Justify Its Valuation

Pfizer (PFE) Signs New Drug Discovery Pact Focused On Sec61 Inhibitors

分享

推荐阅读

Financial Institutions (FISI) Set to Release Quarterly Earnings on Thursday

IBM expects 2026 revenue growth of 4% to 5% while raising free cash flow growth view to more than $1B

Is This Cryptocurrency a Potential Millionaire-Maker?

My father-in-law, 81, sold his $75,000 home and paid off his daughter’s $50,000 debt. What happens to him now?

Nokia reports 9% Q3 sales growth, raises restructuring costs

SPCX Stock Eyes Best Week In Nearly 3 Months — But Analyst Warns Investors May Have To ‘Wait Decades’ To Justify Its Valuation